SURVIVAL AND IMMUNE RESPONSE DATA FROM INTRATUMORAL INT230-6 ALONE (IT-01) AND WITH PEMBROLIZUMAB [KEYNOTE-A10] IN SUBJECTS WITH LOCALLY ADVANCED, UNRESECTABLE AND METASTATIC SOLID TUMORSJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62021-11-100OA
未登录.png){kind=icon}
未登录
